Fred Aslan

ARTV

Fred Aslan serves as President and CEO at Artiva Biotherapeutics, Inc. (ARTV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$364.1K

Net Position

Net Seller

$364.1K

Companies Traded

ARTV

Active Period

May 2025 – Feb 2026

5 total trades

Most Recent

Sell ARTV

Feb 15, 2026 · $58.4K

Fred Aslan's Insider Trading at Artiva Biotherapeutics, Inc. (ARTV)

Buys

0 · $0.00

Sells

5 · $364.1K

Total Shares Bought

Total Shares Sold

90,453

ARTV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Feb 15, 2026↗	Sell	14,600	$4.00	$58.4K
Dec 15, 2025↗	Sell	3,187	$6.00	$19.1K
Nov 15, 2025↗	Sell	12,722	$3.31	$42.1K
Oct 17, 2025↗	Sell	25,500	$6.00	$153.0K
May 15, 2025↗	Sell	34,444	$2.65	$91.4K